What's fueling the biotech engine-2007

被引：36

作者：

Aggarwal, Saurabh

机构：

[1] Saurabh Aggarwal is a healthcare consultant based in New York. saurabhaggarwal@gmail.com,

来源：

NATURE BIOTECHNOLOGY | 2008年 / 26卷 / 11期

关键词：

Compendex;

D O I：

10.1038/nbt1108-1227

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Despite losses in revenue from erythropoietins, historically the highest earner of all biologics, more than 100 biotech drugs continued their upward trend in sales begun in 2006, with antibodies and insulin analogs fueling growth at double-digit rates.

引用

收藏

页码：1227 / 1233

页数：7

相关论文

共 11 条

[1] What's fueling the biotech engine? [J].

Aggarwal, Saurabh .

NATURE BIOTECHNOLOGY, 2007, 25 (10) :1097-1104

[2] An HIV vaccine - Challenges and prospects [J].

Johnston, Margaret I. ;

Fauci, Anthony S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (09) :888-890

[3] Health and economic implications of HPV vaccination in the United States [J].

Kim, Jane J. ;

Goldie, Sue J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (08) :821-832

[4] New drugs for familiar therapeutic targets: thrombopoietin receptor agonists and immune thrombocytopenic purpura [J].

Kuter, David J. .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2008, 80 :9-18

[5] Economic issues with follow-on protein products [J].

Lanthier, Michael ;

Behrman, Rachel ;

Nardinelli, Clark .

NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (09) :733-737

[6]

LONG D, 2008, US PHARM MARKET TREN

[7] Pfizer dumps Exubera [J].

Mack, George S. .

NATURE BIOTECHNOLOGY, 2007, 25 (12) :1331-1332

[8] IL-1 trap go-ahead [J].

Mark Ratner .

Nature Biotechnology, 2008, 26 (5) :485-485

[9] Complement-targeted therapeutics [J].

Ricklin, Daniel ;

Lambris, John D. .

NATURE BIOTECHNOLOGY, 2007, 25 (11) :1265-1275

[10] Toward biosimilar monoclonal antibodies [J].

Schneider, Christian K. ;

Kalinke, Ulrich .

NATURE BIOTECHNOLOGY, 2008, 26 (09) :985-990